Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Jan 2023 for Calithera Biosciences, Inc., €89.
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-41.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Christopher Molineaux: trading record in brief
Christopher Molineaux, listed as senior executive, appears in our data through filings on Calithera Biosciences, Inc. shares, published by SEC (Form 4). We count 20 filings; the first trade dates from 13 July 2015 and the latest from 23 January 2023.
On the market, this insider has only ever bought: 2 purchases, €249k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants and 11 option exercises.
The latest filing, published on 25 January 2023, reports a share grant of €89 in Calithera Biosciences, Inc. The last purchase on record was published on 10 November 2021, which is 1,809 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher Molineaux
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
217 shares@ US$0.44610.1% of flowCommon StockSEC:0000899243-23-002608:0
100,000 shares@ €0.730299.9% of flowCommon StockSEC:0000899243-21-044145:0
Canonical exit: 8 Feb 2022 (T+90)
12,000 shares0Common StockSEC:0000899243-21-043692:0
36,000 shares0Common StockSEC:0000899243-21-042069:0
4 of 4 declarations
